Icariin protects against glucocorticoid-induced osteoporosis in vitro and prevents glucocorticoid-induced osteocyte apoptosis in vivo (Q43824514)

27 November 2017

title

Icariin protects against glucocorticoid-induced osteoporosis in vitro and prevents glucocorticoid-induced osteocyte apoptosis in vivo (English)

1 reference

glucocorticoid-induced osteoporosis

27 November 2017

0 references

1 reference

Rongjie Feng

1

1 reference

27 November 2017

Li Feng

2

1 reference

27 November 2017

Zenong Yuan

3

1 reference

27 November 2017

Dachuan Wang

4

1 reference

27 November 2017

Feng Wang

5

1 reference

27 November 2017

Bingyi Tan

6

1 reference

27 November 2017

Shijie Han

7

1 reference

27 November 2017

Tao Li

8

1 reference

27 November 2017

Dong Li

9

1 reference

27 November 2017

Yong Han

10

1 reference

27 November 2017

publication date

1 September 2013

1 reference

Cell Biochemistry and Biophysics

27 November 2017

published in

1 reference

27 November 2017

volume

67

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

189-197

1 reference

Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Glucocorticoid osteoporosis--mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Intestinal Calcium-Binding Protein and Calcium Absorption in Cortisol-Treated Chicks: Effects of Vitamin D3and 1,25-Dihydroxyvitamin D3*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Mechanisms of glucocorticoid action in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Osteocytes, mechanosensing and Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Corticosteroids and fractures: a close encounter of the third cell kind.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Parathyroid hormone for treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Anabolic therapy in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Antiosteoporotic activity of icariin in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERalpha pathway in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Osteocyte: the unrecognized side of bone tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Mechanical stimulation of MC3T3 osteoblastic cells in a bone tissue-engineering bioreactor enhances prostaglandin E2 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Osteocytes--martyrs for integrity of bone strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Steroid hormone activity of flavonoids and related compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9533-8

10.1007/S12013-013-9533-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1041186864

0 references

1 reference